Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway
Current Issues in Molecular Biology · 08.05.2025 · 47 (5) · 340
DOI: 10.3390/cimb47050340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 08.05.2025. Verfasst von Neslihan Şahin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Bergama State Hospital, 35700 Izmir, Turkey. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Sepsis-associated acute kidney injury (S-AKI) is a severe complication in critically ill patients, marked by inflammation, oxidative stress, and renal dysfunction. This study aimed to evaluate the renoprotective effects of Fasudil (Fas), a Rho-associated kinase inhibitor, in a rat model of S-AKI induced by cecal ligation and puncture (CLP). Thirty-six Wistar albino rats were divided into control, CLP with saline, and Fas (100 mg/kg/day intraperitoneally) groups. Biochemical, histopathological, and molecular analyses were conducted to assess kidney function, oxidative stress, and inflammation. Fas treatment significantly decreased plasma malondialdehyde and TNF-α levels, reducing oxidative stress and systemic inflammation. Kidney function markers, including BUN and creatinine, showed marked improvement. Furthermore, Fas suppressed the expression of STAT-3 and NLRP-3 in renal tissues, highlighting its role in modulating key inflammatory pathways. Histological evaluation revealed alleviated renal damage, with less tubular necrosis and interstitial inflammation in the Fas-treated group. In conclusion, Fas demonstrates significant anti-inflammatory, antioxidant, and nephroprotective effects in S-AKI, primarily by inhibiting STAT-3 and NLRP-3 signaling. These results support its potential as a therapeutic agent in sepsis-induced kidney injury and suggest the need for further clinical evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Bergama State Hospital, 35700 Izmir, Turkey.
- Department of Emergency Medicine, Faculty of Medicine, Izmir Katip Çelebi University, 35620 Izmir, Turkey.
- Faculty of Medicine, Biruni Research Center (BAMER), Biruni University, 34015 Istanbul, Turkey.
ORCID-Profile: Ejder Saylav Bora, Osman Sezer Çınaroğlu
Zitieren
APA
Şahin, N., Bora, E. S., Çınaroğlu, O. S., & Erbaş, O. (2025). Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway. Current Issues in Molecular Biology, 47(5), 340. https://doi.org/10.3390/cimb47050340
Vancouver
Şahin N, Bora ES, Çınaroğlu OS, Erbaş O. Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway. Current Issues in Molecular Biology. 2025;47(5):340. doi:10.3390/cimb47050340
BibTeX
@article{ahin2025,
author = {Şahin, Neslihan and Bora, Ejder Saylav and Çınaroğlu, Osman Sezer and Erbaş, Oytun},
title = {Rho-Associated Kinase Inhibitor Fasudil Protects from Sepsis-Induced Acute Kidney Injury in Rat via Suppressing STAT-3 and NLRP-3 Pathway},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {5},
pages = {340},
doi = {10.3390/cimb47050340}
}
EUVIMED